REGULATORY / DESIGNTF-P01

Synthetic regulatory design

Build an auditable candidate batch from grounded elements, then optimize T-cell activity and off-target leakage as separate objectives.

Target product profileREG-P01 · Discovery cycle 01
ON / On-target statePrimary human T cells

Preserve useful CAR expression across defined activation and manufacturing states.

Measure: % positive · MFI · normalized activity
OFF / Counter-screen statesNormal and malignant plasma/B cells

Treat malignant-cell leakage as an independent gate, not an optional annotation.

Measure: leakage · contrast · detection floor
Advancement rulePass both gates

An average score cannot hide a failed leakage threshold. Rank candidates only after hard gates remain visible.

Pareto rank · reproducibility · context coverage
Lighthouse workflow

A controlled design–build–test–learn cycle

The first cycle stays interpretable. Unconstrained de novo generation is admitted only after this baseline works.

01Grounded library

Curated T-cell regulatory sequences, source evidence and rights

02Motif attribution

Candidate cores, TF motifs, sequence grammar and uncertainty

03Controlled recombination

Fixed core promoter plus named enhancer modules and controls

04Matched wet-lab assay

Continuous activity and leakage in pre-registered cell states

05Learning update

Use every measurement and failure to choose the next batch

Candidate batch

Start with modules we can name, edit and test

CandidateCore promoterEnhancer modulesWhy it existsDesign classState
REG-001TRAC / TCRα coreTCRα module ASingle-module activity baselineReferencegrounded
REG-002TRAC / TCRα coreCD3 module BIndependent T-cell regulatory baselineReferencegrounded
REG-003TRAC / TCRα coreA + BTest non-additive module grammarCombinationproposed
REG-004TRAC / TCRα coreA(mut) + BAttribute the nominated motifControlproposed
4 seed constructs8 diversity-aware slots3 required controls
Quantitative assay contract

The learning signal is a contextual measurement, not a winner label

01On-target activity% positive · MFI · normalized reporter / CAR
02Off-target leakageNormal panel + malignant plasma/B-cell panel
03Specificity contrastON/OFF ratio with raw values retained
04Biological contextDonor · activation · disease state · time point
05Technical contextVector · copy number · integration · replicate
AI stack

What each model is allowed to do

Malinois / CODA

Human sequence-to-activity oracle + iterative proposal search

Research-readyCell-line MPRA; not a T-cell product oracle
DeepSTARR

CNN activity prior + synthetic sequence design

BaselinePrimarily Drosophila enhancer assays
Taskiran design stack

Cell-type-conditioned enhancer design + motif grammar

Research pilotCross-context transfer requires calibration
DNA-Diffusion

Conditional de novo sequence proposals

WatchPreprint; predominantly in-silico evidence
TCRForge local calibrator

Activity–leakage prediction in our assay schema

MissingTrain only after matched continuous data exist
Scientific guardrailsVisible in every decision packet
Motif ≠ function

A motif hit proposes a causal experiment; it does not prove enhancer activity.

Normal specificity ≠ malignant safety

The disease-state counter-screen is a separate gate.

Prediction ≠ measurement

Model scores stay predictions until the exact construct and context are assayed.

Synthetic cassette ≠ TRAC knock-in

Portable regulatory elements and endogenous locus control remain separate architecture arms.